Objectives: The quality of care for dementia in acute-care settings has been criticised. In 2016, the Japanese universal health insurance system introduced a financial incentive scheme for dementia care by dementia specialist teams in acute-care hospitals. This study aimed to investigate the effectiveness of this financial incentive scheme on short-term outcomes (in-hospital mortality and 30-day readmission).
Design And Methods: Using a Japanese nationwide inpatient database, we identified older adult patients with moderate-to-severe dementia admitted for pneumonia, heart failure, cerebral infarction, urinary tract infection, intracranial injury or hip fracture from April 2014 to March 2018. We selected 180 propensity score-matched pairs of hospitals that adopted (n = 180 of 185) and that did not adopt (n = 180 of 744) the financial incentive scheme. We then conducted a patient-level difference-in-differences analysis. In a sensitivity analysis, we restricted the postintervention group to patients who actually received dementia care.
Results: There was no association between a hospital's adoption of the incentive scheme and in-hospital mortality (adjusted odds ratio [aOR]: 0.97; 95% confidence interval [CI]: 0.88-1.06; p = 0.48) or 30-day readmission (aOR: 1.04; 95% CI: 0.95-1.14; p = 0.37). Only 29% of patients in hospitals adopting the scheme actually received dementia care. The sensitivity analysis showed that receiving dementia care was associated with decreased in-hospital mortality.
Conclusions: The financial incentive scheme to enhance dementia care by dementia specialist teams in Japan may not be working effectively, but the results do suggest that individual dementia care was associated with decreased in-hospital mortality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/gps.5537 | DOI Listing |
Open Res Eur
January 2025
Women Engage for a Common Future, Munich, Bavaria, 80331, Germany.
Background: The research within the Citizen Science (CS) project on tenant electricity focused on an inclusive research approach by involving actors such as citizen scientists (CSs), scientists, policymakers, and the private sector. The main objective was to jointly explore the barriers and drivers for and motivations to participate in the tenant electricity model in Germany, and to identify behavioural changes (based on the energy culture concept) of the CSs by being involved in local electricity production and consumption.
Methods: The CS project adopted a mixed-method approach, combining qualitative data analysis from workshops with quantitative data from an energy consumption monitoring scheme and a panel survey on energy-related practices.
Health Econ
March 2025
Department of Public Health, DaCHE, University of Southern Denmark, Odense, Denmark.
Mixed remuneration schemes with capitation and fee-for-service (FFS) payments hold financial incentives to add patients to the list and provide services to listed patients. However, as patients with complex needs tend to require longer consultations there is a risk of inequality in access if fees are not adjusted to patient characteristics. In this paper, we assess a natural experiment introducing additional capitation for GPs with a high share of complex patients (moderate scheme) and for GPs in certain geographical areas (intensive scheme).
View Article and Find Full Text PDFJ Health Organ Manag
March 2025
Indian Institute of Foreign Trade, New Delhi, India.
Purpose: This paper attempts to elucidate the fundamental determinants-both enablers and impediments-that shape a resilient business ecosystem for the medical devices sector in India, with a particular emphasis on sustainable export endeavours under the ambit of the Medical Devices Policy 2023.
Design/methodology/approach: This study dives into India's medical device export firms, analysing factors influencing their performance. By reviewing relevant literature, it identifies regulatory, manufacturing, marketing, distribution and import-related factors.
JAC Antimicrob Resist
February 2025
Australian Antimicrobial Resistance Network (AAMRNet), MTPConnect, Brighton 3186, Australia.
Background: Ensuring timely and equitable access to effective and optimal antimicrobials is crucial for optimal patient care, to minimize the use of less appropriate treatment options and reduce the risk of antimicrobial resistance (AMR).
Objectives: To determine the average time for new antibacterials to gain registration for use in Australia after obtaining marketing approval internationally, and to quantify the use of 'new' and older unregistered antimicrobials in Australian clinical practice between 2018 and 2023.
Methods: Two data sources were utilized to estimate the usage of antimicrobials not registered for use in Australia.
J Environ Manage
March 2025
Thammasat University, 2 Prachan Road, Phranakorn, Bangkok, 10200, Thailand.
In Thailand, the recurring environmental issue of high PM2.5 concentrations from December to April is partly due to pre-harvest sugarcane burning. This practice severely impacts the environment, economy, and public health.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!